Holen Sie sich die Stockscreener-App
67.80
2.56%
-1.8534
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$69.65
Offen:
$69.21
24-Stunden-Volumen:
497.21K
Relative Volume:
0.26
Marktkapitalisierung:
$10.55B
Einnahmen:
$1.17B
Nettoeinkommen (Verlust:
$150.71M
KGV:
72.12
EPS:
0.94
Netto-Cashflow:
$245.03M
1W Leistung:
-1.17%
1M Leistung:
+14.55%
6M Leistung:
+22.71%
1J Leistung:
-11.76%
1-Tages-Spanne:
$67.65
$69.24
1-Wochen-Bereich:
$66.34
$72.16
52-Wochen-Spanne:
$46.01
$79.28
Bio Techne Corp Stock (TECH) Company Profile
Firmenname
Bio Techne Corp
Sektor
Branche
Telefon
612-379-8854
Adresse
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Vergleichen Sie TECH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
67.74 | 10.85B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.63 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.34 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
811.57 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.84 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.19 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-07-09 | Eingeleitet | TD Cowen | Buy |
| 2025-05-30 | Eingeleitet | Wells Fargo | Overweight |
| 2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-02-08 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-08-28 | Eingeleitet | William Blair | Outperform |
| 2023-01-10 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-25 | Bestätigt | The Benchmark Company | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-07-15 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Herabstufung | Stifel | Buy → Hold |
| 2020-05-14 | Eingeleitet | The Benchmark Company | Buy |
| 2020-01-08 | Fortgesetzt | Stephens | Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-02 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-17 | Eingeleitet | Goldman | Neutral |
| 2018-06-15 | Eingeleitet | Argus | Buy |
| 2017-07-13 | Eingeleitet | Wells Fargo | Market Perform |
| 2017-02-09 | Eingeleitet | Citigroup | Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2013-09-20 | Hochstufung | Robert W. Baird | Neutral → Outperform |
Alle ansehen
Bio Techne Corp Aktie (TECH) Neueste Nachrichten
Massachusetts Financial Services Co. MA Trims Stake in Bio-Techne Corp $TECH - MarketBeat
Middle East Exosomes Market Research Report 2025-2033: Diagnostic and Therapeutic Adoption, R&D Investment, and Liquid Biopsy Demand Drive Growth - GlobeNewswire Inc.
How to hear Bio-Techne’s Feb. 4 call on Q2 2026 financials - Stock Titan
Bio-Techne Corp $TECH Shares Bought by Stephens Investment Management Group LLC - MarketBeat
Pembroke Management LTD Purchases 37,189 Shares of Bio-Techne Corp $TECH - MarketBeat
R&D Systems™ Luminex® Portfolio - Select Science
Here's what to expect from Bio-Techne's next earnings report - MSN
Bio-Techne Corp (TECH) Stock Analysis: Potential Upside and Analyst Confidence in the Biotech Arena - DirectorsTalk Interviews
Summit Creek Advisors LLC Sells 16,450 Shares of Bio-Techne Corp $TECH - MarketBeat
Conestoga Capital Advisors LLC Reduces Stake in Bio-Techne Corp $TECH - MarketBeat
HB Wealth Management LLC Sells 15,466 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN
(TECH) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Here's What to Expect From Bio-Techne's Next Earnings Report - Yahoo Finance
StreetInsider.comHere's What to Expect From Bio-Techne's Next Earnings Report - FinancialContent
A Look At Bio-Techne (TECH) Valuation After Analyst Downgrade And Softer Cash Flow Concerns - Yahoo Finance
Bio-Techne Corp. stock outperforms competitors on strong trading day - MSN
What technical signals suggest for Bio Techne Corporation stock - ulpravda.ru
What makes Bio Techne Corporation (TE1) stock appealing to growth investorsJuly 2025 News Drivers & Scalable Portfolio Growth Methods - Улправда
How Bio Techne Corporation (TE1) stock reacts to stronger dollar2025 Retail Activity & Safe Entry Momentum Tips - Улправда
Bio-Techne (NASDAQ:TECH) Stock Acquired Rep. April McClain Delaney - MarketBeat
Rep. April McClain Delaney Purchases Shares of Bio-Techne Corp (NASDAQ:TECH) - MarketBeat
Maryland Representative April McClain Delaney Purchased as Much as $135,000 in Bio-Techne Shares - Bitget
Bio-Techne (NASDAQ:TECH) Cut to Hold at Evercore ISI - MarketBeat
Evercore ISI Group downgrades Bio-Techne (TECH) - MSN
TECH: Evercore ISI Downgrades Bio-Techne's Rating and Lowers Pri - GuruFocus
3 Reasons to Avoid TECH and 1 Stock to Buy Instead - Finviz
Should Bio-Techne’s (TECH) Revenue Miss Raise Doubts About Its Scientific Platform’s Commercial Potential? - simplywall.st
Bio-Techne Corp (NASDAQ:TECH) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Fort Washington Investment Advisors Inc. OH Buys 35,165 Shares of Bio-Techne Corp $TECH - MarketBeat
Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH) - Yahoo Finance
Bio-Techne Corp (TECH): Stock Analysis Reveals A 17.64% Potential Upside For Investors - DirectorsTalk Interviews
Bio-Techne Corp (TECH) Stock Price History & Data - Traders Union
Voya Investment Management LLC Has $7.04 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Assenagon Asset Management S.A. Invests $2.75 Million in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference - Investing News Network
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
Bio-Techne (TECH): Revisiting Valuation as Recent Gains Contrast a Weak One-Year Shareholder Return - Yahoo Finance
Bio-Techne Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Riverbridge Partners LLC Trims Stock Position in Bio-Techne Corp $TECH - MarketBeat
Will Bio Techne Corporation stock gain from strong economyMarket Rally & Free Low Drawdown Momentum Trade Ideas - Улправда
Why Bio Techne Corporation stock appeals to analystsJuly 2025 Momentum & Capital Protection Trade Alerts - Улправда
Will New 3D Multiomic Workflow and Leo System Expansion Change Bio-Techne's (TECH) Narrative? - simplywall.st
How Bio Techne Corporation stock compares to industry benchmarksJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - DonanımHaber
Bio-Techne (NASDAQ:TECH) Downgraded to Strong Sell Rating by Zacks Research - MarketBeat
Trading Action: Will Bio Techne Corporation stock gain from strong economyMarket Volume Summary & Technical Pattern Based Buy Signals - Улправда
Thrivent Financial for Lutherans Has $11.53 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Corient Private Wealth LLC Reduces Stake in Bio-Techne Corp $TECH - MarketBeat
Aaron Wealth Advisors LLC Takes $980,000 Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Finanzdaten der Bio Techne Corp-Aktie (TECH)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.38%
1.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):